{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:16:56Z","timestamp":1768515416417,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1124\/molpharm.123.000752","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T15:05:15Z","timestamp":1705935915000},"page":"194-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["ent-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in Casq2\u2212\/\u2212 Mice"],"prefix":"10.1016","volume":"105","author":[{"given":"Aaron","family":"Gochman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tri Q.","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyungsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob A.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4888-6678","authenticated-orcid":false,"given":"Madelaine P.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paxton A.","family":"Ritschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0921-1835","authenticated-orcid":false,"given":"Abigail N.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn T.","family":"Rebbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendell S.","family":"Akers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razvan L.","family":"Cornea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9919-7661","authenticated-orcid":false,"given":"Derek R.","family":"Laver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0885-636X","authenticated-orcid":false,"given":"Jeffrey N.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4956-9735","authenticated-orcid":false,"given":"Bjorn C.","family":"Knollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.123.000752_bib1","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1073\/pnas.1816685116","article-title":"Unnatural verticilide enantiomer inhibits type 2 ryanodine receptor-mediated calcium leak and is antiarrhythmic","volume":"116","author":"Batiste","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.123.000752_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1124\/molpharm.123.000752_bib3","doi-asserted-by":"crossref","first-page":"e151893","DOI":"10.1172\/jci.insight.151893","article-title":"The Purkinje-myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT","volume":"7","author":"Blackwell","year":"2022","journal-title":"JCI Insight"},{"key":"10.1124\/molpharm.123.000752_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.122.001455","article-title":"ent-Verticilide","volume":"385","author":"Blackwell","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/molpharm.123.000752_bib5","unstructured":"Brunton LL, Knollmann BC (2023) Goodman & Gilman\u2019s the pharmacological basis of therapeutics, 14th ed (McGraw HM, editor), New York."},{"key":"10.1124\/molpharm.123.000752_bib6","doi-asserted-by":"crossref","unstructured":"Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406\u2013412.","DOI":"10.1056\/NEJM198908103210629"},{"key":"10.1124\/molpharm.123.000752_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acsmedchemlett.0c00581","article-title":"Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space","volume":"12","author":"Caron","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/molpharm.123.000752_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.107.157552","article-title":"Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice","volume":"101","author":"Chopra","year":"2007","journal-title":"Circ Res"},{"key":"10.1124\/molpharm.123.000752_bib90","doi-asserted-by":"crossref","first-page":"C724","DOI":"10.1152\/ajpcell.2000.279.3.C724","article-title":"Differential Ca2+ sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin","volume":"279","author":"Fruen","year":"2000","journal-title":"American Journal of Physiology-Cell Physiology"},{"key":"10.1124\/molpharm.123.000752_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2023.04.005","article-title":"The selective RyR2 inhibitor ent-verticilide suppresses atrial fibrillation susceptibility caused by Pitx2 deficiency","volume":"180","author":"Kim","year":"2023","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/molpharm.123.000752_bib10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.RES.0000059562.91384.1A","article-title":"Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling","volume":"92","author":"Knollmann","year":"2003","journal-title":"Circ Res"},{"key":"10.1124\/molpharm.123.000752_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nature06799","article-title":"A genetic framework for improving arrhythmia therapy","volume":"451","author":"Knollmann","year":"2008","journal-title":"Nature"},{"key":"10.1124\/molpharm.123.000752_bib12","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"K\u00f8ber","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/molpharm.123.000752_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCRESAHA.120.316819","article-title":"RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT","volume":"128","author":"Kryshtal","year":"2021","journal-title":"Circ Res"},{"key":"10.1124\/molpharm.123.000752_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00235394","article-title":"Cytoplasmic Ca2+ inhibits the ryanodine receptor from cardiac muscle","volume":"147","author":"Laver","year":"1995","journal-title":"J Membr Biol"},{"key":"10.1124\/molpharm.123.000752_bib15","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients","volume":"91","author":"Leenhardt","year":"1995","journal-title":"Circulation"},{"key":"10.1124\/molpharm.123.000752_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.1124\/molpharm.123.000752_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)80847-8","article-title":"PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts","volume":"101","author":"Marx","year":"2000","journal-title":"Cell"},{"key":"10.1124\/molpharm.123.000752_bib18","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/S0006-3495(03)74976-5","article-title":"Regulation of the calcium release channel from skeletal muscle by suramin and the disulfonated stilbene derivatives DIDS, DBDS, and DNDS","volume":"84","author":"O\u2019Neill","year":"2003","journal-title":"Biophys J"},{"key":"10.1124\/molpharm.123.000752_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ja.2012.12","article-title":"New verticilides, inhibitors of acyl-CoA:cholesterol acyltransferase, produced by Verticillium sp. FKI-2679","volume":"65","author":"Ohshiro","year":"2012","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1124\/molpharm.123.000752_bib20","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/CIRCRESAHA.112.268094","article-title":"Role of RyR2 phosphorylation at S2814 during heart failure progression","volume":"110","author":"Respress","year":"2012","journal-title":"Circ Res"},{"key":"10.1124\/molpharm.123.000752_bib21","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1021\/acschembio.3c00376","article-title":"RyR2 Binding of an Antiarrhythmic Cyclic Depsipeptide Mapped Using Confocal Fluorescence Lifetime Detection of FRET","volume":"18","author":"\u0160eflov\u00e1","year":"2023","journal-title":"ACS Chem Biol"},{"key":"10.1124\/molpharm.123.000752_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ja.2009.126","article-title":"Verticilide, a new ryanodine-binding inhibitor, produced by Verticillium sp. FKI-1033","volume":"63","author":"Shiomi","year":"2010","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1124\/molpharm.123.000752_bib23","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1021\/acsmedchemlett.1c00508","article-title":"Ring Size as an Independent Variable in Cyclooligomeric Depsipeptide Antiarrhythmic Activity","volume":"12","author":"Smith","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/molpharm.123.000752_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/molpharm.123.000720","article-title":"Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring","volume":"104","author":"Takenaka","year":"2023","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.123.000752_bib25","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.108.184457","article-title":"Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure","volume":"103","author":"Terentyev","year":"2008","journal-title":"Circ Res"},{"key":"10.1124\/molpharm.123.000752_bib26","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"key":"10.1124\/molpharm.123.000752_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(96)02149-6","article-title":"Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol","volume":"348","author":"Waldo","year":"1996","journal-title":"Lancet"},{"key":"10.1124\/molpharm.123.000752_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nm.1942","article-title":"Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans","volume":"15","author":"Watanabe","year":"2009","journal-title":"Nat Med"},{"key":"10.1124\/molpharm.123.000752_bib29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jelectrocard.2011.07.025","article-title":"Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy","volume":"44","author":"Watanabe","year":"2011","journal-title":"J Electrocardiol"},{"key":"10.1124\/molpharm.123.000752_bib30","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/hc4301.098254","article-title":"Sudden cardiac death in the United States, 1989 to 1998","volume":"104","author":"Zheng","year":"2001","journal-title":"Circulation"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2400097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2400097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.123.000752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:28:10Z","timestamp":1739957290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X2400097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0026895X2400097X"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.123.000752","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ent-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in Casq2\u2212\/\u2212 Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.123.000752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}